TNF and infection: In terms of the lethal infection model of neonatal mice by HTNV57, treatment with clophosome or the TNFα neutralizing antibody at the early stage (namely 1 day post infection/dpi), but not the progressive stage (namely 5 dpi), could effectively improve the disease outcome (Supplementary Fig. 4a, b).